Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PBRM1 | Q86U86 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | BACE1 | P56817 | 6/20 | 0.37 |
| ▸ | CTSD | P07339 | 2/20 | 0.37 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | BCHE | P06276 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 3/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10237762 | 1.00 | PBRM1 (0.48) | PBRM1MEN1KMT2ACYP19A1CYP3A4 | |
| SCHEMBL9932355 | 1.00 | PBRM1 (0.48) | PBRM1MEN1KMT2ACYP19A1CYP3A4 | |
| SCHEMBL10279619 | 1.00 | PBRM1 (0.48) | PBRM1MEN1KMT2ACYP19A1CYP3A4 | |
| SCHEMBL9882485 | 1.00 | PBRM1 (0.48) | PBRM1MEN1KMT2ACYP19A1CYP3A4 | |
| SCHEMBL9882486 | 0.84 | PBRM1 (0.42) | PBRM1MEN1KMT2ABACE1CTSD | |
| SCHEMBL9931915 | 0.84 | PBRM1 (0.42) | PBRM1MEN1KMT2ABACE1CTSD | |
| SCHEMBL9931914 | 0.84 | PBRM1 (0.42) | PBRM1MEN1KMT2ABACE1CTSD | |
| SCHEMBL10279618 | 0.84 | PBRM1 (0.42) | PBRM1MEN1KMT2ABACE1CTSD | |
| SCHEMBL10237761 | 0.84 | PBRM1 (0.42) | PBRM1MEN1KMT2ABACE1CTSD | |
| SCHEMBL10237763 | 0.79 | PBRM1 (0.51) | PBRM1MEN1KMT2ACYP19A1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120157448-A1 | COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES | GENENTECH, INC. | 2012-06-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120157448-A1 | COMPOUNDS FOR TREATING NEURODEGENERATIVE DISEASES | BACE1, PSEN1, PSEN2 | PBRM1 3853/4885MEN1 3061/4885KMT2A 4037/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.